These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12949693)

  • 1. Clinical evaluation of non-narcotic substitutive effects produced by ANAR during the therapy of patients with heroin abuse.
    Krylov EN
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():183-8. PubMed ID: 12949693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ANAR for the therapy of opium withdrawal syndrome.
    Gofman AG; Krylov EN; Kozhinova TA; Nizhnichenko TI; Khanykov VV; Sheveleva OS; Epstein OI; Yashkina IV
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():181-2. PubMed ID: 12949692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of potentiated preparations to relieve alcohol and opium withdrawal syndromes.
    Aleksandrova NV; Gofman AG; Krylov EN; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():163-6. PubMed ID: 12949688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proproten-100 in the therapy of patients with the alcohol withdrawal syndrome.
    Gofman AG; Pyatnitskaya IN; Valentik YV; Krylov EN; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():167-70. PubMed ID: 12949689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in immunological parameters in patients with opium abuse receiving ANAR therapy.
    Vetlugina TP; Ivanova SA; Bokhan NA; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():189-91. PubMed ID: 12949694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detoxification of heroin dependence by buprenorphine.
    Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on Fu-Yuan Pellet, a traditional chinese medicine formula for detoxification of heroin addictions.
    Wang X; Li J; Huang M; Kang L; Hu M
    Am J Drug Alcohol Abuse; 2009; 35(6):408-11. PubMed ID: 20014908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opium and heroin addicts in Laos. II. A study of matched pairs.
    Westermeyer J; Peng G
    J Nerv Ment Dis; 1977 May; 164(5):351-4. PubMed ID: 864449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tai-Kang-Ning, a Chinese herbal medicine formula, alleviates acute heroin withdrawal.
    Kang L; Li B; Gao L; Li S; Wang D; Hu M; Li J
    Am J Drug Alcohol Abuse; 2008; 34(3):269-76. PubMed ID: 18428069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of oral slow release morphine for maintenance treatment in heroin addicts: a 6-month open noncomparative study.
    Vasilev GN; Alexieva DZ; Pavlova RZ
    Eur Addict Res; 2006; 12(2):53-60. PubMed ID: 16543739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial.
    Moeini M; Omidi A; Sehat M; Banafshe HR
    Eur Addict Res; 2019; 25(1):41-47. PubMed ID: 30630161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid heroin detoxification using a single high dose of buprenorphine.
    Kutz I; Reznik V
    J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing acute withdrawal syndrome on patients with heroin and morphine addiction by acupuncture therapy.
    Lu PK; Lu GP; Lu DP; Lu DP; Lu WI
    Acupunct Electrother Res; 2004; 29(3-4):187-95. PubMed ID: 15807100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detoxification of high dose heroin addicts in Pakistan.
    Gossop M
    Drug Alcohol Depend; 1989 Oct; 24(2):143-50. PubMed ID: 2791889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid (vitamin C) effects on withdrawal syndrome of heroin abusers.
    Evangelou A; Kalfakakou V; Georgakas P; Koutras V; Vezyraki P; Iliopoulou L; Vadalouka A
    In Vivo; 2000; 14(2):363-6. PubMed ID: 10836211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy in overdose and withdrawal syndrome in heroin addicts].
    Arrizabalaga Cuesta C; Zulaica D
    Rev Enferm; 1985 Feb; 8(78):23-5. PubMed ID: 3845677
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary evaluation of epidural morphine for treatment of heroin withdrawal.
    Langerman L; Abu-Nasra T; Finger J; Tverskoy M; Kook AI; Mizrukhin A
    J Clin Anesth; 2001 Sep; 13(6):452-4. PubMed ID: 11578891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment.
    González-Saiz F; Lozano Rojas O; Trujols J; Alcaraz S; Siñol N; Pérez de Los Cobos J;
    Drug Alcohol Depend; 2018 Feb; 183():127-133. PubMed ID: 29247974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrodotoxin alleviates acute heroin withdrawal syndrome: a multicentre, randomized, double-blind, placebo-controlled study.
    Song H; Li J; Lu CL; Kang L; Xie L; Zhang YY; Zhou XB; Zhong S
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):510-4. PubMed ID: 21575032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
    Ge Y; Li M; Sun WL; Cai ZJ
    Yao Xue Xue Bao; 1994; 29(4):256-60. PubMed ID: 7976340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.